Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

April 1, 2025

Conditions
Plantar Fasciitis of Both FeetPainFunction
Interventions
DRUG

Incobotulinum Toxin A

will be administered 2 ampoules (200 IU) of Incobotulinum toxin , injectable solution presentation 100 IU ampoule with powder diluted in 1 ml of 0.9% saline solution in a single application at 4 points, in addition to a therapeutic exercise program in the teaching service to later do it at home that will be done daily for 4 months (cryotherapy for 15 minutes on the plantar fascia, active mobilizations of the ankle and foot for 5 minutes, stretching exercises for the triceps surae and plantar fascia for 20 seconds, 3 repetitions, strengthening of intrinsic muscles of the foot).

DRUG

Glucocorticoid

Program in which 2 ml of dexamethasone will be administered in an 8 mg/2 ml ampoule diluted in 2 ml of lidocaine injectable solution in a 50 ml bottle (20 mg/ml) in a single application at 1 point, in addition to a therapeutic exercise program in the teaching service to later do it at home that will be done daily for 4 months (cryotherapy for 15 minutes on the plantar fascia, active mobilizations of the ankle and foot for 5 minutes, stretching exercises for the triceps surae and plantar fascia for 20 seconds, 3 repetitions, strengthening of intrinsic muscles of the foot).

Trial Locations (1)

97000

"Hospital General Regional No.1 Lic. Ignacio García Téllez IMSS, Calle 41 101, Fénix, 97155 Mérida, Yuc.", Mérida

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT06788158 - Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis | Biotech Hunter | Biotech Hunter